The first modifier gene identified, the endoplasmic reticulum mannosidase I (ERmanI), came from a candidate approach in a gene-sequencing study and suggested that differences in ERmanI expression were associated with an earlier age-of-onset of end-stage liver disease [11]. Here, MAN1B1 is linked to End Stage Liver Disease.